We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+10.04%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$37.9B
AUM Growth
–
Cap. Flow
+$36.1B
Cap. Flow
% of AUM
95.33%
Top 10 Holdings %
Top 10 Hldgs %
21.49%
Holding
1,659
New
1,659
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.39B |
| 2 |
Apple
AAPL
|
+$1.38B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$896M |
| 4 |
Amazon
AMZN
|
+$820M |
| 5 |
Johnson & Johnson
JNJ
|
+$601M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.62% |
| 2 | Healthcare | 15.12% |
| 3 | Financials | 15.09% |
| 4 | Consumer Discretionary | 10.34% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Q32 Bio
QTTB
$450M
| $268K | ﹤0.01% |
+719
| New | +$206K |
|
1602
Q2 Holdings
QTWO
$3.42B
| $258K | ﹤0.01% |
+3,177
| New | +$244K |
|
1603
Stoke Therapeutics
STOK
$1.82B
| $256K | ﹤0.01% |
+9,073
| New | +$228K |
|
|
EVBG
1604
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $256K | ﹤0.01% |
+3,276
| New | +$253K |
|
1605
Heron Therapeutics
HRTX
$86.3M
| $253K | ﹤0.01% |
+10,739
| New | +$238K |
|
1606
Adaptive Biotechnologies
ADPT
$3.56B
| $252K | ﹤0.01% |
+8,448
| New | +$243K |
|
1607
Triumph Financial Inc
TFIN
$1.84B
| $251K | ﹤0.01% |
+6,600
| New | +$228K |
|
1608
Healthcare Realty
HR
$7.42B
| $250K | ﹤0.01% |
+8,258
| New | +$247K |
|
|
MTEM
1609
DELISTED
Molecular Templates, Inc.
MTEM
| $245K | ﹤0.01% |
+1,168
| New | +$168K |
|
1610
Algonquin Power & Utilities
AQN
$4.69B
| $224K | ﹤0.01% |
+15,800
| New | +$219K |
|
|
WORK
1611
DELISTED
Slack Technologies, Inc.
WORK
| $220K | ﹤0.01% |
+9,777
| New | +$218K |
|
1612
Syndax Pharmaceuticals
SNDX
$1.84B
| $204K | ﹤0.01% |
+23,219
| New | +$171K |
|
|
PVLA
1613
Palvella Therapeutics
PVLA
$1.98B
| $201K | ﹤0.01% |
+693
| New | +$192K |
|
|
VRNT
1614
DELISTED
Verint Systems
VRNT
| $200K | ﹤0.01% |
+7,077
| New | +$172K |
|
|
ENV
1615
DELISTED
ENVESTNET, INC.
ENV
| $199K | ﹤0.01% |
+2,860
| New | +$186K |
|
1616
Grocery Outlet
GO
$891M
| $197K | ﹤0.01% |
+6,078
| New | +$196K |
|
1617
SiriusPoint
SPNT
$2.98B
| $195K | ﹤0.01% |
+18,500
| New | +$180K |
|
1618
CAE Inc. Common Shares
CAE
$8.1B
| $191K | ﹤0.01% |
+7,204
| New | +$185K |
|
1619
SAP
SAP
$187B
| $190K | ﹤0.01% |
+1,415
| New | +$186K |
|
1620
Kura Oncology
KURA
$922M
| $183K | ﹤0.01% |
+13,294
| New | +$197K |
|
1621
Ambarella
AMBA
$2.99B
| $176K | ﹤0.01% |
+2,905
| New | +$161K |
|
1622
Kinross Gold
KGC
$28.5B
| $176K | ﹤0.01% |
+37,121
| New | +$168K |
|
1623
Alector
ALEC
$164M
| $174K | ﹤0.01% |
+10,087
| New | +$171K |
|
|
ALTR
1624
DELISTED
Altair Engineering Inc
ALTR
| $165K | ﹤0.01% |
+4,595
| New | +$155K |
|
|
ATYR
1625
aTyr Pharma
ATYR
$46.4M
| $158K | ﹤0.01% |
+37,884
| New | +$146K |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Ensign Peak Advisors, which disclosed 1,659 positions worth $37.9B. Its ten largest holdings account for 21% of the portfolio.
Its largest position is Microsoft: 9,487,124 shares worth $1.5B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q4 2019 buy was Microsoft: 9,487,124 shares worth $1.5B.
- Ensign Peak Advisors's ten largest holdings make up 21% of its $37.9B portfolio in Q4 2019.
- Ensign Peak Advisors disclosed 1,659 positions in Q4 2019, its first 13F filing on record.
Based on Ensign Peak Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.